Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Tumour”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04521686
What this trial is testing

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Who this might be right for
CholangiocarcinomaChondrosarcomaGlioma+1 more
Eli Lilly and Company 200
Not applicableStudy completedNCT04772469
What this trial is testing

Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

Who this might be right for
Human Immunodeficiency VirusAcquired Immunodeficiency SyndromeHIV Infections+5 more
University of California, San Francisco 934
Early research (Phase 1)Study completedNCT02264886
What this trial is testing

Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies

Who this might be right for
Central Thorax CancerLiver CancerNon-Liver Abdominal Cancer
Washington University School of Medicine 30
Not applicableLooking for participantsNCT06357754
What this trial is testing

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic LeukaemiaMultiple Myeloma
Bristol-Myers Squibb 50
Testing effectiveness (Phase 2)Ended earlyNCT02421354
What this trial is testing

Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis

Who this might be right for
HepatomegalyMyelofibrosis Transformation in Essential ThrombocythemiaPolycythemia Vera, Post-Polycythemic Myelofibrosis Phase+2 more
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT03654105
What this trial is testing

Screening and Multiple Intervention on Lung Epidemics

Who this might be right for
InflammationSmoking CessationDiet Modification+2 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT05726370
What this trial is testing

Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck CancerResectable Head and Neck Squamous Cell Carcinoma+2 more
Dana-Farber Cancer Institute 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT02911142
What this trial is testing

Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma

Who this might be right for
Primary Effusion LymphomaB-Cell Neoplasm
National Cancer Institute (NCI) 17
Not applicableNot Yet RecruitingNCT06923670
What this trial is testing

Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History

Who this might be right for
Polycythemia VeraEssential ThrombocythaemiaMyelofibrosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 496
Testing effectiveness (Phase 2)Study completedNCT03391973
What this trial is testing

Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)

Who this might be right for
Carcinoma of Unknown Primary
AHS Cancer Control Alberta 33
Not applicableStudy completedNCT03090386
What this trial is testing

Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients

Who this might be right for
Brain Tumor
Mayo Clinic 30
Testing effectiveness (Phase 2)Study completedNCT01664923
What this trial is testing

Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer

Who this might be right for
Prostate Cancer
Pfizer 396
Testing effectiveness (Phase 2)Study completedNCT04323657
What this trial is testing

TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
Non Hodgkin LymphomaAcute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma+3 more
TCR2 Therapeutics 6
Early research (Phase 1)Study completedNCT00004257
What this trial is testing

Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer

Who this might be right for
Esophageal Cancer
Albany Medical College
Not applicableStudy completedNCT01346839
What this trial is testing

Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care

Who this might be right for
Colon CancerLung CancerProstate Cancer
Baylor College of Medicine 1,256
Not applicableLooking for participantsNCT06712095
What this trial is testing

Video Capsule Examination in Patients With Lynch Syndrome

Who this might be right for
Lynch SyndromeLi Fraumeni SyndromePTEN Hamartoma Syndrome+7 more
Royal Marsden NHS Foundation Trust 25
Testing effectiveness (Phase 2)Study completedNCT01146795
What this trial is testing

Neoadjuvant Therapy for Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
Jason D. Wright 32
Large-scale testing (Phase 3)Study completedNCT03027557
What this trial is testing

Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.

Who this might be right for
Primary HyperparathyroidismParathyroid AdenomaParathyroid Hyperplasia
Peter Vestergaard 46
Large-scale testing (Phase 3)Study completedNCT00793377
What this trial is testing

Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer

Who this might be right for
Primary Breast Cancer
GBG Forschungs GmbH 913
Post-approval studies (Phase 4)Not Yet RecruitingNCT07490509
What this trial is testing

Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer

Who this might be right for
AbemaciclibAbemaciclib-related DiarrheaBreast Cancer
Poitiers University Hospital 235
Next Page